Products & Services
Home > Products & Services
Studium Genetics has developed and patented the Oral Carcinoma Risk Algorithm (SG-OCRA™) method for the early detection of patients at risk to develop Oral Squamous Cells Carcinoma (OSCC) and its precursor, high grade dysplasia, by quantitative DNA methylation analysis using bisulfite Next Generation Sequencing (NGS) in exfoliating brushes of oral mucosa.
The markers involved in this invention are a set of 13 genes in which the aberrant methylation pattern is indicative of severe dysplasia and/or OSCC
The DNA methylation analysis of 13 genes is eventually used to perform a calculationby using an internally developed and patented algorithm that generates a score. This will help physicians to identify those patients at risk for oral cancer.
Genes2Me, leading international manufacturer of genetic tests, has selected Innovagene Life Sciences as a strategic partner to bring innovative technology in genetics and molecular biology to Italy. A new project “LAB2ME” has been announced by Innovagene to create a new model of smart laboratories 2.0 with fast and cost effective solutions for patients who needs fast test results in genetics and genomics for chronic diseases, pathologies and infections.
STAY TURNED!!!